Androgen deprivation therapy is a lifesaving therapy used by thousands of men each year, but some patients are warning of ...

"Outside of metastatic castrate-resistant prostate cancer, both NCCN and ASCO do note that an osteoclast inhibitor (at ...

A mainstay of prostate cancer treatment at all stages is a type of hormone therapy called androgen deprivation therapy (ADT). And, newer hormone therapies and combinations with chemotherapy can ...

Androgen deprivation therapy (ADT) becomes less effective over time, but additional therapies like androgen receptor blockers and androgen synthesis inhibitors may extend life and improve the ...

Androgen deprivation (AD) therapy for prostate cancer is being used in an increasingly wide range of settings, such as advanced disease, loco-regional disease, as an adjunct to surgery or ...

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

Time to Benefit of Androgen Deprivation Therapy in Patients With Localized Prostate Cancer Undergoing Radiotherapy. JCO Precis Oncol 9 , e2400605 (2025). DOI: 10.1200/PO-24-00605 ...

EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission ...

“Transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT): Efficacy and safety of combining with androgen receptor pathway inhibitors (ARPIs) in metastatic (M1) prostate ...

Home; Articles; Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the ...